Fig. 1From: Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy for medically inoperable, early-stage non-small cell lung cancerSchematic presentation of the Markov model structure for medical inoperable NSCLC treatmentBack to article page